Andreas Scherer

7.1k total citations
49 papers, 1.1k citations indexed

About

Andreas Scherer is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Nephrology. According to data from OpenAlex, Andreas Scherer has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 8 papers in Nephrology. Recurrent topics in Andreas Scherer's work include Renal cell carcinoma treatment (11 papers), Renal and related cancers (10 papers) and Molecular Biology Techniques and Applications (8 papers). Andreas Scherer is often cited by papers focused on Renal cell carcinoma treatment (11 papers), Renal and related cancers (10 papers) and Molecular Biology Techniques and Applications (8 papers). Andreas Scherer collaborates with scholars based in Finland, Norway and Switzerland. Andreas Scherer's co-authors include Hans‐Peter Marti, Friedrich Raulf, Jonathan M. Graff, Andreas Krause, John R. Walker, Alexander Korn, D. Niese, Øystein Eikrem, Markus Vähä‐Koskela and Krister Wennerberg and has published in prestigious journals such as Journal of Biological Chemistry, Bioinformatics and PLoS ONE.

In The Last Decade

Andreas Scherer

49 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Scherer Finland 20 530 159 158 149 141 49 1.1k
N. Lynn Henry United States 13 302 0.6× 147 0.9× 74 0.5× 289 1.9× 42 0.3× 43 1.1k
William A. Hammond United States 8 297 0.6× 119 0.7× 43 0.3× 184 1.2× 111 0.8× 17 1.1k
Kenjiro Nakamura Japan 22 303 0.6× 377 2.4× 296 1.9× 36 0.2× 824 5.8× 50 1.8k
Shingo Yano Japan 23 478 0.9× 108 0.7× 28 0.2× 85 0.6× 88 0.6× 173 1.9k
Sílvia Pineda Spain 15 309 0.6× 183 1.2× 71 0.4× 567 3.8× 115 0.8× 29 1.1k
Roger Strair United States 21 783 1.5× 97 0.6× 10 0.1× 209 1.4× 80 0.6× 68 1.6k
Jake Shortt Australia 25 1.3k 2.5× 113 0.7× 13 0.1× 172 1.2× 70 0.5× 119 2.3k
Lorena Martinez‐Gamboa Germany 14 373 0.7× 95 0.6× 6 0.0× 153 1.0× 64 0.5× 29 1.0k
Aurora González‐Fierro Mexico 21 1.0k 1.9× 127 0.8× 7 0.0× 233 1.6× 85 0.6× 46 1.5k
Gabriele Zoppoli Italy 23 848 1.6× 215 1.4× 24 0.2× 550 3.7× 226 1.6× 96 1.9k

Countries citing papers authored by Andreas Scherer

Since Specialization
Citations

This map shows the geographic impact of Andreas Scherer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Scherer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Scherer more than expected).

Fields of papers citing papers by Andreas Scherer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Scherer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Scherer. The network helps show where Andreas Scherer may publish in the future.

Co-authorship network of co-authors of Andreas Scherer

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Scherer. A scholar is included among the top collaborators of Andreas Scherer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Scherer. Andreas Scherer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Jingcheng, Yaqing Liu, Jun Shang, et al.. (2023). The Quartet Data Portal: integration of community-wide resources for multiomics quality control. Genome biology. 24(1). 245–245. 7 indexed citations
2.
Marti, Hans‐Peter, Lili Liu, Krzysztof Kiryluk, et al.. (2023). Glomerular transcriptomics predicts long term outcome and identifies therapeutic strategies for patients with assumed benign IgA nephropathy. Kidney International. 105(4). 717–730. 7 indexed citations
3.
Võikar, Vootele, Plínio Casarotto, Enrico Glerean, et al.. (2023). The Finnish Reproducibility Network (FIRN): A national bottom-up approach to scientific integrity in a global context. Aaltodoc (Aalto University). 1 indexed citations
4.
Gonzalo‐Calvo, David de, Monica Marchese, Jan Hellemans, et al.. (2022). Consensus guidelines for the validation of qRT-PCR assays in clinical research by the CardioRNA consortium. Molecular Therapy — Methods & Clinical Development. 24. 171–180. 19 indexed citations
5.
Scherer, Andreas, Øystein Eikrem, Christian Beisland, et al.. (2022). A multiomics disease progression signature of low-risk ccRCC. Scientific Reports. 12(1). 13503–13503. 6 indexed citations
6.
Gool, Alain J. van, Florence Biétrix, Eric Caldenhoven, et al.. (2017). Bridging the translational innovation gap through good biomarker practice. Nature Reviews Drug Discovery. 16(9). 587–588. 43 indexed citations
7.
Finne, Kenneth, Hans‐Peter Marti, Sabine Leh, et al.. (2016). Proteomic Analysis of Minimally Damaged Renal Tubular Tissue from Two-Kidney-One-Clip Hypertensive Rats Demonstrates Extensive Changes Compared to Tissue from Controls. ˜The œNephron journals/Nephron journals. 132(1). 70–80. 8 indexed citations
8.
Eikrem, Øystein, Christian Beisland, Andreas Scherer, et al.. (2016). Development and confirmation of potential gene classifiers of human clear cell renal cell carcinoma using next-generation RNA sequencing. Scandinavian Journal of Urology. 50(6). 452–462. 17 indexed citations
9.
Hartmann, Nicole, Evert J. Luesink, Joseph D. Szustakowski, et al.. (2014). The use of haplotype-specific transcripts improves sample annotation consistency. Biomarker Research. 2(1). 17–17. 1 indexed citations
10.
Jensen, Jens‐Michael, Andreas Scherer, C. A. Wanke, et al.. (2011). Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis. Allergy. 67(3). 413–423. 60 indexed citations
11.
Jensen, Jens‐Michael, Kerstin Ahrens, Josef G. Meingassner, et al.. (2011). Differential suppression of epidermal antimicrobial protein expression in atopic dermatitis and in EFAD mice by pimecrolimus compared to corticosteroids. Experimental Dermatology. 20(10). 783–788. 31 indexed citations
12.
Scherer, Andreas, et al.. (2011). A subset of metzincins and related genes constitutes a marker of human solid organ fibrosis. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 458(4). 487–496. 15 indexed citations
13.
Günther, Oliver P., Robert Balshaw, Andreas Scherer, et al.. (2009). Functional Genomic Analysis of Peripheral Blood During Early Acute Renal Allograft Rejection. Transplantation. 88(7). 942–951. 30 indexed citations
14.
Scherer, Andreas, Friedrich Raulf, Céline C. Berthier, et al.. (2009). Renal Allografts with IF/TA Display Distinct Expression Profiles of Metzincins and Related Genes. American Journal of Transplantation. 9(3). 517–526. 53 indexed citations
15.
Scherer, Andreas, Wilfried Gwinner, Michael Mengel, et al.. (2009). Transcriptome changes in renal allograft protocol biopsies at 3 months precede the onset of interstitial fibrosis/tubular atrophy (IF/TA) at 6 months. Nephrology Dialysis Transplantation. 24(8). 2567–2575. 35 indexed citations
16.
Scherer, Andreas, Meike Körner, Ute Eisenberger, et al.. (2009). Meta-Analyses Qualify Metzincins and Related Genes as Acute Rejection Markers in Renal Transplant Patients. American Journal of Transplantation. 10(2). 286–297. 22 indexed citations
17.
Pichler, Irene, Christian Fuchsberger, Francesca Zolezzi, et al.. (2008). Differential gene expression analysis of ovarian cancer in a population isolate.. PubMed. 29(4). 357–63. 3 indexed citations
18.
Papoian, Ruben, Andreas Scherer, Muriel Saulnier, et al.. (2005). VeloceGenomics: An Accelerated in Vivo Drug Discovery Approach to Rapidly Predict the Biologic, Drug-Like Activity of Compounds, Proteins, or Genes. Pharmaceutical Research. 22(10). 1597–1613. 3 indexed citations
19.
Deliveliotis, Ch., et al.. (1999). Multiple Transrectal Ultrasound Guided Prostatic Biopsies: Morbidity and Tolerance. International Urology and Nephrology. 31(5). 681–686. 22 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N. Lynn Henry Breakdown of academic impact, for papers by William A. Hammond Breakdown of academic impact, for papers by Kenjiro Nakamura Breakdown of academic impact, for papers by Shingo Yano Breakdown of academic impact, for papers by Sílvia Pineda Breakdown of academic impact, for papers by Roger Strair Breakdown of academic impact, for papers by Jake Shortt Breakdown of academic impact, for papers by Lorena Martinez‐Gamboa Breakdown of academic impact, for papers by Aurora González‐Fierro Breakdown of academic impact, for papers by Gabriele Zoppoli
Rankless by CCL
2026